Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration

Journal of Vector Borne Diseases

Volumn 52, Issue 4, 2015, Pages 314-320

  Khan, A M ^a   Dutta, P ^a   Sarmah, C K ^a   Baruah, N K ^a   Das, S ^a   Pathak, A K ^a   Sarmah, P ^a   Hussain, M E ^a   Mahanta, J ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

Author keywords

Assam; Culex quinquefasciatus; Lymphatic filariasis; Mass drug administration; Microfilaria; Wuchereria bancrofti

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; ANTIFILARIAL AGENT; TEA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGRICULTURAL WORKER; ARTICLE; BLOOD ANALYSIS; BLOOD SMEAR; CHILD; CLINICAL FEATURE; CULEX QUINQUEFASCIATUS; DISEASE CONTROL; ELEPHANTIASIS; ENDEMIC DISEASE; FEMALE; GIEMSA STAIN; HEALTH CARE DELIVERY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYDROCELE; INDIA; INFECTION RATE; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; MASS DRUG ADMINISTRATION; MICROFILARIA (NEMATODE LARVA); NONHUMAN; PARASITE EXAMINATION; PARASITE VIRULENCE; PREVALENCE; SEX DIFFERENCE; TEA; WUCHERERIA BANCROFTI; ANIMAL; CULEX; DRUG EFFECTS; ELEPHANTIASIS, FILARIAL; GROWTH, DEVELOPMENT AND AGING; INSECT VECTOR; ISOLATION AND PURIFICATION; MIDDLE AGED; PARASITOLOGY; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CHILD; CULEX; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; HUMANS; INDIA; INSECT VECTORS; MALE; MIDDLE AGED; PREVALENCE; TEA; WUCHERERIA BANCROFTI; YOUNG ADULT;

EID: 84955621371     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Global programme to eliminate lymphatic filariasis: Progress report 2014. Wkly Epidemiol Rec 2015; 90(38): 489–504.
2. Srivastava PK, Bhattacharjee J, Dhariwal AC, Krishnamoorthy K, Dash AP. Elimination of lymphatic filariasis –Current status and way ahead. J Commun Dis 2014; 46(2): 85–94.
3. Khan AM, Dutta P, Khan SA, Mahanta J. A focus of lymphatic filariasis in a tea garden worker community of central Assam. J Environ Biol 2004; 25(4): 437–40.
4. Mahanta B, Handique R, Narain K, Dutta P, Mahanta J. Transmission of Bancroftian filariasis in tea agro-ecosystem of Assam, India. Southeast Asian J Trop Med Public Health 2001; 32(3): 581–4.
5. Khan AM, Dutta P, Khan SA, Mohapatra PK, Baruah NK, Sharma CK. et al. Lymphatic filariasis in two distinct communities of upper Assam. J Commun Dis 1999; 31(2): 101–6.
6. Khan AM, Dutta P, Khan SA, Baruah NK, Sharma CK, Mahanta J. Bancroftian filariasis in a weaving community of lower Assam. J Commun Dis 1999; 31(1): 61–2.
7. Prakash A, Mohapatra PK, Das HK, Sharma RK, Mahanta J. Bancroftian filariasis in Namrup tea estate, District Dibrugarh, Assam. Indian J Public Health 1998; 42(4): 103–7.
8. Khan AM, Dutta P, Khan SA. Evaluation of microfilaria prevalence and disease after mass drug administration (MDA) programme for the eradication of lymphatic filariasis in Assam. Annual Report 2007–08. Dibrugarh: Regional Medical Research Centre (ICMR) 2008; p. 47–8.
9. Brady M. Global alliance to eliminate lymphatic filariasis. Seventh meeting of the Global alliance to eliminate lymphatic filariasis: Reaching the vision by scaling up, scaling down, and reaching out. Parasit Vector 2014; 7: 46.
10. Srivastava PK, Dhillon GP. Elimination of lymphatic filariasis in India: A successful endeavour. J Indian Med Assoc 2008; 106(10): 673–4.
11. Health information of India–Population exposed to the risk of filariasis. New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare, Govt. of India 1991; p. 150.
12. Ramaiah KD, Vanamail P, Das PK. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass drng administration of diethylcarbamazine. Trans R Soc Trop Med Hyg 2007; 101(3): 250–5.
13. Simonsen PE, Derua YA, Magesa SM, Pedersen EM, Stensgaard AS, Malecela MN, et al. Lymphatic filariasis control in Tanga region, Tanzania: Status after eight rounds of mass drug administration. Parasit Vector 2014; 7(1): 507.
14. Sunish IP, Munirathinam A, Kalimuthu M, Ashok KV, Tyagi BK. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations. J Trop Pediatr 2014; 60(3): 245–8.
15. Babu BV, Babu GR. Coverage of, and compliance with mass drug administration under the programme to eliminate lymphatic filariasis in India: A systematic review. Trans R Soc Trop Med Hyg 2014; 108(9): 538–49.
16. Hussain MA, Sitha AK, Swain S, Kadam S, Pati S. Mass drug administration for lymphatic filariasis elimination in a coastal state of India: A study on barriers to coverage and compliance. Infect Dis Poverty 2014; 3: 31.
17. Offei M, Anto F. Compliance to mass drug administration programme for lymphatic filariasis elimination by community members and volunteers in the Ahanta West District of Ghana. J Bacteriol Parasitol 2014; 5: 180.
18. Kumar A, Kumar P, Nagaraj K, Nayak D, Ashok L, Ashok K. A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India. J Vector Borne Dis 2009; 46: 237–40.
19. Lahariya C, Tomar SS. How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions. J Vector Borne Dis 2011; 48(1): 1–6.
20. Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis 2013; 7(11): e2447.
21. Mukhopadhyay AK. Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme. J Vector Borne Dis 2010; 47(1): 55–7.
22. Khan AM, Mahanta J. Lymphatic filariasis eradication programme. Curr Sci 2005; 88(11): 1718–9.
23. Small ST, Ramesh A, Bun K, Reimer L, Thomsen E, Baea M, et al. Population genetics of the filarial worm Wuchereria bancrofti in a post-treatment region of Papua New Guinea: Insights into diversity and life history. PLoS Negl Trop Dis 2013; 7(7): e2308.
24. Sharma OP, Vadlamudi Y, Kota AG, Sinha VK, Kumar MS. Drug targets for lymphatic filariasis: A bioinformatics approach. J Vector Borne Dis 2013; 50(3): 155–62.
25. Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: An evaluation study. J Vector Borne Dis 2008; 45(4): 313–20.